Loss to follow-up in “test and treat era” and its predictors among HIV-positive adults receiving ART in Northwest Ethiopia: Institution-based cohort study

BackgroundPeople living with HIV/AIDS are enrolled in lifelong Anti-Retroviral Treatment (ART) irrespective of their clinical staging as well as CD4 cell count. Although this “Universal Test and Treat” strategy of ART was found to have numerous benefits, loss from follow-up and poor retention remain...

Full description

Bibliographic Details
Main Authors: Berihun Bantie, Awole Seid, Gashaw Kerebeh, Animut Alebel, Getenet Dessie
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2022.876430/full